Kite

This sponsor has funded 3 studies across 10 countries.

PAS funded by this sponsor.
EU PAS ID Status Title Protocol uploaded Results uploaded
32539 Ongoing Long-term, Non-interventional Study of Recipients of Yescarta® for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Primary... Yes No
45813 Planned Long-term, Non-interventional Study of Recipients of Tecartus for Treatment of Adult Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) Yes No
104052 Ongoing Tecartus Survey: Quantitative Testing of Health Care Professional Knowledge About Tecartus® Risk Minimisation Measures Yes No

PAS by Risk Management Plan (RMP) requirement

Kite

The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.

Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.